{"id":"W3017839166","doi":"10.1016/j.jaad.2020.04.104","title":"The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"ca_institutions":"Innovaderm (Canada)","funders":"Samsung Bioepis; Cilag; Maruho; Merck Sharp and Dohme; LEO Pharma; Medac; AbbVie; Glenmark Pharmaceuticals; Fresenius Medical Care North America; Janssen Biotech; Les Laboratories Pierre Fabre; Galápagos; Valeant Pharmaceuticals International; Sun Pharma; School of Public Health, University of California Berkeley; Miltenyi Biotec; Regeneron Pharmaceuticals; Kiniksa Pharmaceuticals; Pfizer; Biogen; Novartis; Celgene; Procter and Gamble; Sanofi; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Almirall; Galderma; Asana Biosciences; Bristol-Myers Squibb; Eli Lilly and Company","keywords":"Atopic dermatitis; Medicine; Reliability (semiconductor); Dermatology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01274711,0.0006532021,0.0009240347,0.00138379,0.0004388535,0.0008235717,0.0008212974,0.0007094219,0.0008297461],"category_scores_gemma":[0.01519045,0.0002450202,0.001263644,0.0008716036,0.0004998042,0.0009058102,0.001428259,0.001202714,0.0003528299],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005517614,"about_ca_system_score_gemma":0.001014203,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001210137,"about_ca_topic_score_gemma":0.002717931,"domain_scores_codex":[0.9903281,0.004074852,0.0009960968,0.0009013904,0.0034475,0.0002521132],"domain_scores_gemma":[0.9908814,0.003551737,0.002268791,0.0005841518,0.002447164,0.000266724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002852512,0.001372607,0.8073249,0.0004723209,0.001112569,0.0001143084,0.0008632632,0.001932278,0.008724189,0.000919056,0.003349552,0.1709624],"study_design_scores_gemma":[0.0006088815,0.004100989,0.978323,0.0001309631,0.0003866579,0.0006716291,0.0002604105,0.006028479,0.003557371,0.0007279647,0.005137602,0.00006603547],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.9619854,0.002776895,0.02338648,0.0003488244,0.0003080811,0.002585107,0.003033617,0.0002206688,0.005355002],"genre_scores_gemma":[0.9613553,0.0009002491,0.03111838,0.0002705576,0.0001310606,0.001895544,0.003104811,0.00007277696,0.001151289],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.01274711,"threshold_uncertainty_score":0.06741399,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1220590217899888,"score_gpt":0.3860614693203945,"score_spread":0.2640024475304057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}